P
Pandorum Technologies
Bengaluru based biotech startup
About Pandorum Technologies
Pandorum Technologies, founded in 2011 by Tuhin Bhowmick and Arun Chandru, is a biotechnology company operating in the field of regenerative medicine.
The company is focused on tissue engineering, specifically developing functional human tissues through its proprietary 3D bioprinting technology platform. This process involves the precise layer-by-layer printing of cells to create tissues that mimic the function of natural human organs.
Its primary products are bio-engineered tissues, with a notable focus on creating a 3D bio-printed liver and cornea. These tissues are intended for two main applications: medical research and therapeutic use. For research, these tissues provide a more accurate and humane alternative to animal testing for drug discovery and development. In the long term, the company aims for its bio-engineered tissues to be used for therapeutic applications, addressing the global shortage of organs for transplantation.
The business model centers on leveraging its technology platform for developing and commercializing these tissues. The company serves pharmaceutical companies and research institutions that require advanced models for preclinical studies. Pandorum Technologies is a venture-backed company, having secured Series A funding to advance its research and development efforts.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Bengaluru, India
- Employees
- 44
- Open positions
- None listed
- Dealroom signal
- 74.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Mar 2024 | $11M | $44M | Ashish Kacholia · Sunil Kant Munjal · Indian Angel Network · Everest Financial Services | ↗ |
| EARLY VC✓Equity / VC | Oct 2021 | $4.8M | $28M | Sunil Kant Munjal | — |
Growth signals
Latest recorded traffic for Pandorum Technologies is 180 monthly website visits, down 66% over the last three months. Pandorum Technologies's team grew 2.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A10 investors entered at this stage
500 Global
Sunil Kant Munjal
Indian Angel Network
Binny Bansal- CICapital Trust India
Kotak Mahindra Bank
BTB Ventures- AKAshish Kacholia
Everest Financial Services- APAcebright Pharma
Other known investors2 additional known investors
Indian Institute of Science
MBC Biolabs
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pandorum Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pandorum Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.